Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MDCXW
Upturn stock ratingUpturn stock rating

Medicus Pharma Ltd. Warrant (MDCXW)

Upturn stock ratingUpturn stock rating
$2.5
Last Close (24-hour delay)
Profit since last BUY110.08%
upturn advisory
Regular Buy
BUY since 66 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: MDCXW (3-star) is a REGULAR-BUY. BUY since 66 days. Profits (110.08%). Updated daily EoD!

Upturn Star Rating

rating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

rating

0 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

Analysis of Past Performance

Type Stock
Historic Profit 94.86%
Avg. Invested days 40
Today’s Advisory Regular Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 4.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 0.35 - 4.10
Updated Date 06/28/2025
52 Weeks Range 0.35 - 4.10
Updated Date 06/28/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

ai summary icon Upturn AI SWOT

Medicus Pharma Ltd. Warrant

stock logo

Company Overview

overview logo History and Background

Medicus Pharma Ltd. Warrant's history and background are not publicly available. Warrant details are tied to Medicus Pharma, Inc., a now defunct company. This analysis will focus on information generally applicable to warrants as a financial instrument.

business area logo Core Business Areas

  • Warrant Trading: Warrants are derivative securities that give the holder the right, but not the obligation, to buy company stock at a specific price before a certain date. Warrant holders can buy or sell the warrants themselves.

leadership logo Leadership and Structure

Warrants do not have their own leadership or organizational structure; their value is derived from the underlying company. In this case the warrant related to Medicus Pharma, Inc. which is no longer in existence.

Top Products and Market Share

overview logo Key Offerings

  • Warrant Trading: The offering here is the *right* to purchase the underlying stock. Market share is not applicable in the conventional sense for a warrant, because it does not represent a business segment with competitors, but rather a financial mechanism that may have many different underlying assets to which it is applicable. The value will be based on the price and time left until expiration. Competitors are other securities that are applicable to the underlying stock.

Market Dynamics

industry overview logo Industry Overview

The warrant market is a subset of the broader derivatives market. It allows investors to gain leveraged exposure to underlying assets.

Positioning

The warrant's position is directly tied to the underlying stock (Medicus Pharma, Inc.). However, given Medicus Pharma, Inc.'s status, this warrant likely has minimal to no value. Warrants provide leveraged exposure but also carry higher risk.

Total Addressable Market (TAM)

The TAM for warrants is immense, covering all tradable derivatives. The specific warrant for Medicus Pharma would have been linked to Medicus Pharma's market capitalization and future expectations which given the company being defunct would likely result in a zero total market value.

Upturn SWOT Analysis

Strengths

  • Potential for high leverage
  • Relatively low cost compared to the underlying stock (when active)

Weaknesses

  • High risk of loss
  • Time decay (value decreases as expiration approaches)
  • Often illiquid

Opportunities

  • Potential for high returns with minimal capital outlay (when the underlying stock performs well)
  • Hedging tool

Threats

  • Expiration worthless if the stock price doesn't reach the strike price
  • Market volatility impacting underlying stock
  • Company-specific risks affecting the underlying stock, such as going defunct

Competitors and Market Share

competitor logo Key Competitors

Competitive Landscape

Not applicable as there are no specific competitors for a warrant other than instruments on the underlying asset

Growth Trajectory and Initiatives

Historical Growth: Warrant's value tracked the growth of the underlying stock, Medicus Pharma, Inc.

Future Projections: Given that Medicus Pharma is defunct, there are no positive future projections.

Recent Initiatives: Not applicable; Medicus Pharma no longer exists.

Summary

Medicus Pharma Ltd. Warrant represents the right to purchase stock in Medicus Pharma, Inc. Given the fact that Medicus Pharma, Inc. is defunct, it is highly unlikely this warrant will have any value. This warrant's value is derived solely from the underlying company's stock performance. Due to the nature of Medicus Pharma's current status, investors holding this warrant are likely to experience significant or total loss.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • General knowledge of warrants and derivative markets
  • Information regarding Medicus Pharma, Inc.'s status.

Disclaimers:

This analysis is based on the assumption that Medicus Pharma Ltd. Warrant is directly tied to the now-defunct Medicus Pharma, Inc. Investing in warrants involves substantial risk and should only be considered by sophisticated investors who understand the risks involved. This is not investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Medicus Pharma Ltd. Warrant

Exchange NASDAQ
Headquaters Toronto, ON, Canada
IPO Launch date 2024-11-14
CEO & Executive Chairman Dr. Raza Bokhari M.B.A., M.D., MBA
Sector Healthcare
Industry Drug Manufacturers - General
Full time employees -
Full time employees -

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets. It develops SkinJect for the treatment of basal cell carcinoma. The company was founded in 2015 and is headquartered in Toronto, Canada.